The page is the record's research on the issuer — no analyst, no rating, no view. # Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Orchestra BioMed Holdings, Inc., listed on NASDAQ under ticker OBIO, with ISIN US68572M1062. The LEI is not on the record, because no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 3841 Surgical & Medical Instruments & Apparatus, the jurisdiction is United States, Delaware, and the segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 81 filings on 46 filing days in the window 2025-11-08 to 2026-11-08, of which 50 are directors' dealings and 15 are regulatory filings. The median gap between filing days is 4 days. The latest filing is dated 2026-11-06, two days before the record date of 2026-11-08, and is of type prospectus. For NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. For the sector the median filings count is 64, the median cadence gap is 6 days and the median latency is 4 days across 129 issuers. The issuer's 81 filings are above the NASDAQ median of 52 and above the sector median of 64. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, since EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, since the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001814114.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/OBIO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/OBIO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/OBIO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp